Search results for "Highlights"
SGLT-2s, GLP-1s linked with lower hyperkalemia rate than DPP-4s
Initiating therapy with sodium-glucose cotransporter-2 (SGLT-2) inhibitors was associated with the lowest risk of hyperkalemia in a retrospective comparison with glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors.
https://diabetes.acponline.org/archives/2024/07/12/3.htm
12 Jul 2024
Subscribe
ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.
https://diabetes.acponline.org/subscribe/index.html
Spotlight on gut microbiota in diabetes
A forum and a narrative review summarized current knowledge about the connections between diabetes and gut microbiota, while a new study identified certain species within patients' microbiomes that could relate to diabetes.
https://diabetes.acponline.org/archives/2024/07/12/5.htm
12 Jul 2024
Semaglutide associated with increased cases of optic neuropathy, study finds
An observational study suggests a potential risk of nonarteritic anterior ischemic optic neuropathy associated with semaglutide, but more research is needed to assess causality, the study authors said.
https://diabetes.acponline.org/archives/2024/07/12/2.htm
12 Jul 2024
Societies offer guidance on treatment of hyperglycemic crises
An updated consensus statement from several diabetes and endocrinology organizations provides recommendations on the diagnosis, treatment, and prevention of diabetic ketoacidosis and hyperglycemic hyperosmolar state.
https://diabetes.acponline.org/archives/2024/07/12/1.htm
12 Jul 2024
Report and study highlight risk of heart failure in patients with diabetes
The American Diabetes Association made recommendations on diagnosing and treating heart failure in patients with diabetes, and a study found increased risk of progression to clinical heart failure in those with an HbA1c level of 7% or above.
https://diabetes.acponline.org/archives/2022/06/10/1.htm
10 Jun 2022
Hyper-, hypokalemia with SGLT-2 inhibitors related to eGFR decrease after initiation
A decline of more than 30% in estimated glomerular filtration rate (eGFR) after initiation of sodium-glucose cotransporter-2 (SGLT-2) inhibitor therapy was associated with higher risk for hyperkalemia and hypokalemia in an observational study from Taiwan.
https://diabetes.acponline.org/archives/2024/05/10/2.htm
10 May 2024
Evening workouts associated with lower mortality in type 2 diabetes
Patients with type 2 diabetes and obesity who worked out in the evening had greater reductions in risk for mortality and cardiovascular and microvascular disease than those who exercised in the morning or afternoon, a retrospective study found.
https://diabetes.acponline.org/archives/2024/05/10/3.htm
10 May 2024
Statins may affect diabetes risk primarily in patients with prediabetes
There was a dose-response relationship between statin use and new diabetes diagnoses, with most cases seen in patients whose glycemic markers were close to the diagnostic threshold for diabetes at baseline, an individual-patient meta-analysis found.
https://diabetes.acponline.org/archives/2024/04/12/2.htm
12 Apr 2024
About 5 in 1,000 U.S. adults have type 1 diabetes, 4 in 1,000 kids
In addition to a U.S. study assessing rates of type 1 diabetes in different age groups, a Swedish study looked at differences by age in whether patients' relatives also had the disease, finding that it was likely more tied to genetics in childhood-onset cases.
https://diabetes.acponline.org/archives/2024/04/12/3.htm
12 Apr 2024